Criteria for antibody titers against measles, mumps, and rubella in the 2014 JSIPC guidelines [4].

Criteria for antibody titers against measles, mumps, and rubella in the 2014 JSIPC guidelines [4].</p

Flow chart detailing subject selection in the vaccination implementation program and this study.

Flow chart detailing subject selection in the vaccination implementation program and this study.</p

Antibody titer response to the entire vaccination protocol.

Antibody titer response to the entire vaccination protocol.</p

Correlation between vaccine type and adverse event frequency.

Correlation between vaccine type and adverse event frequency.</p

The relevance of the antibody titer increment effect and vaccine type.

The relevance of the antibody titer increment effect and vaccine type.</p

Combinations of negative or intermediate antibody titers in 467 HCWs and inoculated vaccines.

Combinations of negative or intermediate antibody titers in 467 HCWs and inoculated vaccines.</p

Seropositivity ratio by age groups (females).

Seropositivity ratio by age groups (females).</p

Demographic characteristics and disposition of participants.

Demographic characteristics and disposition of participants.</p

Seropositivity ratio by age groups (males).

Seropositivity ratio by age groups (males).</p

Effect of vaccines on achieving cut-off values in HCWs with negative or intermediate antibody titers.

Effect of vaccines on achieving cut-off values in HCWs with negative or intermediate antibody titers.</p